CTD // Fund

Keio Innovation Initiative

Stage agnostic tech and life sciences focused venture capital firm investing primarily in Japan

Keio Innovation Initiative

Japan

Keio Innovation Initiative is an institutional investor (Conventional VCs) founded in 2015 and headquartered in Tokyo, Japan. Keio Innovation Initiative is a satge agnostic venture capital firm. Makes investments in territories such as Japan. Invests in tech and life sciences companies that are operating in sectors like Biopharma, HealthTech and SportsTech. Notable investments include Kringle Pharma, CureApp, BONX. Notable portfolio companies: Kringle Pharma, CureApp, BONX.

Stage: seed, early-stage, Series A, Series B, growth, seed, early-stage, Series A, Series B, growth
Check size: $1M-$15M
HQ: Tokyo, Japan
Founded: 2015
Website: https://www.keio-innovation.co.jp/
LinkedIn: https://linkedin.com/company/keio-innovation-initiative-inc
Twitter: http://twitter.com/keio_innovation

Institutional Investordeep techdigital technologymedical healthcarebiotechITAIroboticsspace techquantum techagritech

What they look for

Academia-originated deep tech startups, primarily commercializing Keio University research (expanded to other universities/research institutes), Japan-focused, leveraging innovative technology/scientific knowledge for large societal impact (healthcare, productivity, environment), high difficulty projects

Related startups

📊 Valuation calculator for deal screening — free tool using revenue multiples by sector and round.

⚠️ Common pitch mistakes we see →

Preparing to pitch Keio Innovation Initiative?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →

Keio Innovation Initiative

Keio Innovation Initiative

What they look for

Related startups

Nanofiber Quantum Technologies

Fermelanta

Space Quarters

Preparing to pitch Keio Innovation Initiative?